Compound ID | 1312
ASN-100
Class: Antibody (monoclonal antibody [mAb])
| Spectrum of activity: | Gram-positive |
| Details of activity: | Failed to prove its effectiveness in high-risk, mechanically ventilated patients with S. aureus pneumonia |
| Institute where first reported: | Arsanis |
| Highest developmental phase: | Phase 2 |
| Development status: | Inactive |
| External links: | |
| Citation: | Failed to prove its effectiveness in high-risk, mechanically ventilated patients with S. aureus pneumonia |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.